Results 1 to 10 of about 77,001 (260)

N-/T-Type vs. L-Type Calcium Channel Blocker in Treating Chronic Kidney Disease: A Systematic Review and Meta-Analysis

open access: yesPharmaceuticals, 2023
Renin-angiotensin system (RAS) inhibitors and calcium channel blockers (CCB) are often used together in chronic kidney disease (CKD). The PubMed, EMBASE, and Cochrane Library databases were searched to identify randomized controlled trials (RCTs) in ...
Mingming Zhao   +9 more
doaj   +3 more sources

High-Dose Insulin Euglycemic Therapy in Concomitant Beta-Blocker and Calcium Channel Blocker Overdose [PDF]

open access: yesJournal of Investigative Medicine High Impact Case Reports
Beta-blockers and calcium channel blockers are among the most commonly used drugs in the adult population, and the National Poison Data System annual reports note 11 075 beta-blocker overdoses and 6256 calcium-channel blocker overdoses in 2022. Poisoning
Varun Roperia MD   +2 more
doaj   +2 more sources

Calcium Channel Blocker Toxicity: A Practical Approach [PDF]

open access: yesJournal of Multidisciplinary Healthcare, 2022
Omar A Alshaya,1– 3 Arwa Alhamed,3,4 Sara Althewaibi,1 Lolwa Fetyani,1 Shaden Alshehri,1 Fai Alnashmi,1 Shmeylan Alharbi,1– 3 Mohammed Alrashed,1– 3,5 Saleh F Alqifari,6 Abdulrahman I Alshaya1– 3 1Department of Pharmacy Practice, College of Pharmacy ...
Alshaya OA   +9 more
doaj   +2 more sources

Calcium Channel Blocker Overdose. [PDF]

open access: yesJ Educ Teach Emerg Med
Emergency medicine residents and medical students on emergency medicine rotation.Calcium channel blocker (CCB) overdoses can be severe with potentially serious adverse outcomes. CCBs work by blocking the calcium channels on smooth and cardiac muscle tissue. At low dose ranges, dihydropyridine CCBs (such as nifedipine, amlodipine, and nicardipine) block
Andrusaitis JG, Givertz A.
europepmc   +4 more sources

Effect of Dihydropyridine Calcium Channel Blocker on Mortality of Hypertension Patients With Moderate-Severe Pulmonary Acute Respiratory Distress Syndrome: A Multicenter Retrospective Observational Cohort Study

open access: yesCritical Care Explorations, 2021
OBJECTIVES:. The aim was to evaluate the effect of dihydropyridine calcium channel blocker on the prognosis for moderate-severe pulmonary acute respiratory distress syndrome in hypertension patients. DESIGN:.
Fengyuan Li, MD   +9 more
doaj   +1 more source

Development of severe junctional bradycardia after dexmedetomidine infusion in a polypharmacy patient: a case report and literature review [PDF]

open access: yesKosin Medical Journal, 2023
The authors report a case of newly manifested severe junctional bradycardia following dexmedetomidine administration during spinal anesthesia in a polypharmacy patient.
Soeun Jeon   +5 more
doaj   +1 more source

Intravenous calcium therapy in calcium channel blocker poisoning – A double-edged sword [PDF]

open access: yesJournal of Anaesthesiology Clinical Pharmacology
Balaji Rajaram   +3 more
doaj   +2 more sources

TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS

open access: yesРациональная фармакотерапия в кардиологии, 2015
Data about the current approach to the choice of dual antihypertensive combinations in various clinical situations for treatment of hypertension are presented.
A. M. Shilov   +3 more
doaj   +3 more sources

Calcium channel blockers

open access: yesMedicine, 2003
Overdose of calcium channel blockers is potentially lethal. Verapamil and diltiazem are much more dangerous than dihydropyridines. Hypotension with (verapamil and diltiazem) or without (dihydropyridines) heart block and bradycardia are the most important features.
Buckley, Nicholas   +2 more
openaire   +2 more sources

Calcium Channel Blocker Overdose Simulation

open access: yesMedEdPORTAL, 2015
Introduction Accidental poisoning and drug overdose are a common occurrence in the emergency medicine setting. Often it is unknown what substances the patient has taken.
Michael Maniaci   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy